Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma

被引:24
|
作者
Lei, Xiong [1 ]
Li, Yun-feng [1 ]
Chen, Guo-dong [1 ]
Ou, Di-peng [2 ]
Qiu, Xiao-xin [3 ]
Zuo, Chao-hui [3 ]
Yang, Lian-Yue [1 ,2 ]
机构
[1] Cent South Univ, Xiangya Hosp, Liver Canc Lab, Changsha 410008, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Surg, Changsha 410008, Hunan, Peoples R China
[3] Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, Dept Abdominal Surg Oncol, Changsha 410013, Hunan, Peoples R China
基金
国家高技术研究发展计划(863计划); 中国国家自然科学基金;
关键词
Ack1; hepatocellular carcinoma; prognosis; metastasis; TYROSINE KINASE; LIVER RESECTION; ACTIVATION; AKT/PKB; PATHWAY; CELLS; RHOC; PHOSPHORYLATION; RECURRENCE; EXPRESSION;
D O I
10.18632/oncotarget.5872
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite the substantial data supporting the oncogenic role of Ack1, the predictive value and biologic role of Ack1 in hepatocellular carcinoma (HCC) metastasis remains unknown. In this study, both correlations of Ack1 expression with prognosis of HCC, and the role of Ack1 in metastasis of HCC were investigated in vitro and in vivo. Our results showed that Ack1 was overexpressed in human HCC tissues and cell lines. High Ack1 expression was associated with HCC metastasis and determined as a significant and independent prognostic factor for HCC after liver resection. Ack1 promoted HCC invasion and metastasis in vitro and in vivo. Mechanistically, we confirmed that Ack1 enhanced invasion and metastasis of HCC via EMT by mediating AKT phosphorylation. In conclusion, our study shows Ack1 is a novel prognostic biomarker for HCC and promotes metastasis of HCC via EMT by activating AKT signaling.
引用
收藏
页码:40622 / 40641
页数:20
相关论文
共 50 条
  • [41] Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma
    Li, Dezhi
    Cheng, Xianyi
    Zheng, Wei
    Chen, Junhui
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 4923 - 4935
  • [42] Overexpression of RASAL1 indicates poor prognosis and promotes invasion of ovarian cancer
    Chang, Rui-Xia
    Cui, Ai-Ling
    Dong, Lu
    Guan, Su-Ping
    Jiang, Ling-Yan
    Miao, Cong-Xiu
    [J]. OPEN LIFE SCIENCES, 2019, 14 (01): : 133 - 140
  • [43] Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma
    Hiroki Honda
    Masaaki Takamura
    Satoshi Yamagiwa
    Takuya Genda
    Ryoko Horigome
    Naruhiro Kimura
    Toru Setsu
    Kentaro Tominaga
    Hiroteru Kamimura
    Yasunobu Matsuda
    Toshifumi Wakai
    Yutaka Aoyagi
    Shuji Terai
    [J]. Scientific Reports, 7
  • [44] Overexpression of dishevelled 2 is involved in tumor metastasis and is associated with poor prognosis in hepatocellular carcinoma
    C. Zhang
    C. Li
    X. Chen
    Y. Zhou
    B. Yin
    R. Ni
    Y. Zhang
    J. Liu
    [J]. Clinical and Translational Oncology, 2017, 19 : 1507 - 1517
  • [45] Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma
    Honda, Hiroki
    Takamura, Masaaki
    Yamagiwa, Satoshi
    Genda, Takuya
    Horigome, Ryoko
    Kimura, Naruhiro
    Setsu, Toru
    Tominaga, Kentaro
    Kamimura, Hiroteru
    Matsuda, Yasunobu
    Wakai, Toshifumi
    Aoyagi, Yutaka
    Terai, Shuji
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [46] Overexpression of dishevelled 2 is involved in tumor metastasis and is associated with poor prognosis in hepatocellular carcinoma
    Zhang, C.
    Li, C.
    Chen, X.
    Zhou, Y.
    Yin, B.
    Ni, R.
    Zhang, Y.
    Liu, J.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (12): : 1507 - 1517
  • [47] Immunohistochemical Co-overexpression of CPEB1 and GPC3 Indicates Poor Prognosis in Hepatocellular Carcinoma
    Cao, Wenqing
    Imam, Rami
    Yu, Jiangzhou
    [J]. MODERN PATHOLOGY, 2018, 31 : 626 - 627
  • [48] CEP131 indicates poor prognosis and promotes cell proliferation and migration in hepatocellular carcinoma
    Liu, Xu-Hui
    Yang, Yu-Feng
    Fang, Heng-Ying
    Wang, Xue-Hua
    Zhang, Mei-Fang
    Wu, Dan-Chun
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2017, 90 : 1 - 8
  • [49] Immunohistochemical Co-overexpression of CPEB1 and GPC3 Indicates Poor Prognosis in Hepatocellular Carcinoma
    Cao, Wenqing
    Imam, Rami
    Yu, Jiangzhou
    [J]. LABORATORY INVESTIGATION, 2018, 98 : 626 - 627
  • [50] The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis
    Ha, Sang Yun
    Kim, Jeong Hoon
    Yang, Jung Wook
    Kim, Jimin
    Kim, Binnari
    Park, Cheol-Keun
    [J]. CANCER RESEARCH AND TREATMENT, 2016, 48 (03): : 1065 - 1073